BioSpace News Archive

The agreement supports a vision of personalized healthcare to Qatar’s population and beyond

For the past 13 years, Novus Health has helped organizations and their employees, members and customers navigate the complex health care systems around the world.

The company will host a conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT the same day to review results and provide a business update.

Bioelectronic medicine scientists at The Feinstein Institute for Medical Research collaborated with counterparts from Academic Medical Center at University of Amsterdam in the Netherlands to carry out a series of pilot clinical studies to assess the effect of a novel bioelectronic stimulation.

PD-L1 IHC 22C3 pharmDx Can Now Be Used to Identify a Broader Range of NSCLC Patients for First-line Treatment With KEYTRUDA® (pembrolizumab)

The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention, along with state and local officials, are investigating a multi-state outbreak of Salmonella Newport infections linked to frozen ground tuna imported into the U.S. by Jensen Tuna and sourced from JK Fish of Vietnam.

Turning Point Therapeutics, Inc. announced the pricing of its initial public offering of 9,250,000 shares of its common stock at a price to the public of $18.00 per share.

Covera Health announced the formation of a distinguished clinical advisory committee to support the company’s Radiology Centers of Excellence program, which is saving lives and demonstrating the value of high-quality radiological care nationwide.

Company promotes two industry veterans into newly-created Operations and Global Commercial roles

Next-generation assay aids in diagnosing heart attacks faster and more accurately, and is enabled on the company’s newest analyzer, the VITROS® XT 7600 Integrated System